Relay Therapeutics, Inc. (RLAY) Operating cash flow 2019–2025
Relay Therapeutics, Inc. (RLAY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$235.5MFY2025 · since FY2019: -$66.1M → -$235.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$235.5M | +5.5% |
| FY2024 | -$249.1M | +17.1% |
| FY2023 | -$300.3M | -30.9% |
| FY2022 | -$229.5M | -208.4% |
| FY2021 | -$74.4M | +27.4% |
| FY2020 | -$102.5M | -55.0% |
| FY2019 | -$66.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RLAY financial trends
RLAY RevenueRLAY Net incomeRLAY Net marginRLAY Gross profitRLAY Gross marginRLAY Operating incomeRLAY Operating marginRLAY Free cash flowRLAY Capital expendituresRLAY Return on equityRLAY Stock buybacksRLAY Dividends paidRLAY Total assetsRLAY Total liabilitiesRLAY Shareholders’ equityRLAY overview →